Active, Not Recruiting
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
NCT03983954
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
- Locations
-
- Shalby Hospital Ahmedabad, Gujarat, India
- National Cancer Institute Jhajjar, Haryana, India
- All India Institute of Medical Sciences New Delhi, India
- PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India